Your veterinarian will decide the length of treatment with Kinavet-CA1®. Regular checkups with your veterinarian are required.
Always READ Client Information Sheet with prescription.
Administer KINAVET-CA1 at an initial dose of 12.5 mg/kg/day (5.7 mg/lb/day) orally, once daily with food . Dose reductions to 9 mg/kg/day (4.1 mg/lb/day) and dose interruptions may be utilized, if needed, to manage adverse reactions (see WARNINGS and PRECAUTIONS). Do not split or crush tablets
Has your pet has been diagnosed with a mast cell tumor, by a qualified veterinarian. The cancer type is also called MCT or mastocytoma. Mastocytoma (MCT) is among the most common forms of cancer in dogs.
Mast cells are cells that are found in the connective tissues, especially those vessels and nerves that are closest to the external surfaces (e.g., skin, lungs, nose, mouth). Their primary function of the cells include defense against parasitic infestations, tissue repair, and the formation of new blood vessels (angiogenesis). They are also associated with allergic reactions, since they contain several types of dark granules made up of various chemicals, including histamine and heparin, serving biologically to modify immune reactions and inflammation. Mast cells are derived from the bone marrow, and can be found in various tissues throughout the body.
The origin of Mastocytoma is a deregulated proliferation of normal cells in the skin (mast cells) that leads to a dangerously abnormal growth of these cells and formation of a tumor.
It is not contagious to humans or other animals.
Mast cell tumors (or mastocytomas) are graded according to their location in the skin, presence of inflammation, and how well they are differentiated. MCT has various forms and varies widely in size, shape, appearance, texture, and location. These tumors often behave in an aggressive manner, spreading to secondary body locations (metastasizing) and releasing chemicals that cause systemic problems such as loss of appetite, vomiting, diarrhea, abdominal pain, itchiness, lethargy, and anemia. If left untreated, MCT can be lethal and will very probably have a negative effect on your dog’s lifespan and quality of life.
Boxers, bulldogs, pugs, and Boston terriers appear to be more susceptible to mast cell tumors than other breeds. The mean age for the development of this condition is eight years in dogs, though it has been reported in animals less than one year of age.
Up to 25 percent of skin tumors in dogs and cats are mast cell tumors. These tumors often behave in an aggressive manner, metastasizing to local lymph nodes, the liver, spleen, and bone marrow.
Kinavet-CA1® is a cutting-edge technology working directly at the origin of the tumor.
Kinavet-CA1® belongs to the family of drugs called tyrosine kinase receptor inhibitors, which over the last decade have helped to revolutionize the management of certain human cancers and have now been successfully developed for veterinary medicine.
This targeted therapy inhibits cellular signaling pathways that regulate key cell functions and survival. Responses vary from complete disappearance of the tumor to no impact at all. However, clinical studies demonstrated that 62% of dogs treated by Kinavet-CA1® were still alive after 12 months of therapy.
Treatment With Kinavet- CA1